Arix Bioscience : to Participate in Fireside Chat at the Jefferies Virtual Healthcare Conference

Arix Bioscience plc

Arix to Participate in Fireside Chat at the Jefferies Virtual Healthcare Conference

LONDON, 3 June 2020: Arix Bioscience plc ("Arix", LSE: ARIX), a global venture capital company focused on investing in and building breakthrough biotech companies, today announces that Jonathan Tobin, PhD, Managing Director, is scheduled to participate in an analyst led fireside chat at the Jefferies Virtual Healthcare Conference on Thursday, 4 June 2020, at 11am EDT/4pm BST.

A live webcast of the fireside chat will be available on the investor relations section of Arix's website at

https://arixbioscience.com/investor-relations/events-presentations. After the conference, an archived replay

will be available on the company's website at the same address.

[ENDS]

Enquiries

For more information on Arix, please contact:

Arix Bioscience plc

Charlotte Parry, Head of Investor Relations [phone]

[e-mail]

Optimum Strategic Communications

Mary Clark, Supriya Mathur, Shabnam Bashir

[e-mail]

About Arix Bioscience plc

Arix Bioscience plc is a global venture capital company focused on investing in and building breakthrough biotech companies around cutting edge advances in life sciences.

We collaborate with exceptional entrepreneurs and provide the capital, expertise and global networks to help accelerate their ideas into important new treatments for patients. As a listed company, we are able to bring this exciting growth phase of our industry to a broader range of investors.

www.arixbioscience.com